skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Acridine-intercalator based hypoxia selective cytotoxins

Patent ·
OSTI ID:869193

Hypoxia selective cytotoxins of the general formula ##STR1## wherein n is from 1 to 5, and NO.sub.2 is in at least one of the 2, 4 or 5-positions of the imidazole. Such compounds have utility as radiosensitizers and chemosensitizers.

Research Organization:
Univ. of Pittsburgh, PA (United States)
DOE Contract Number:
FG02-89ER60869
Assignee:
University of Pittsburgh (Pittsburgh, PA)
Patent Number(s):
US 5294715
OSTI ID:
869193
Country of Publication:
United States
Language:
English

References (26)

Radiation sensitization and chemopotentiation: Rsu 1069, a compound more efficient than misonidazole in vitro and in vivo journal May 1984
NLA-1 : A 2-nitroimidazole radiosensitizer targeted to DNA by intercalation journal January 1992
Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygen journal April 1983
A new ruthenium radiosensitizer: RuC12(DMSO)2(4-Nitroimidazole)2 journal July 1986
Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508 journal September 1984
Induction of Tumour Hypoxia Post-irradiation: A Method for Increasing the Sensitizing Efficiency of Misonidazole and RSU 1069 in Vivo journal January 1989
High-Pressure Oxygen and Radiotherapy journal May 1955
Binding Mode of 2-amino-5-nitrothiazole (ANT) in Platinum Complexes, Trans -[PtCl 2 (ANT) 2 ], Affects DNA Binding, Toxicity and Radiosensitizing Ability journal January 1987
Chemotherapy of Cancer journal March 1978
Further Studies on Toxic and Radiosensitizing Properties of Ruthenium Complexes of 4-nitroimidazoles journal January 1987
Radiosensitization of mammalian cells by transition metal complexes containing nitroimidazole ligands journal August 1984
Reductive metabolism and hypoxia-selective toxicity of nitracrine journal July 1986
Hypoxia-selective Radiosensitization of Mammalian Cells by Nitracrine, an Electron-affinic DNA Intercalator
  • Roberts, Peter B.; Anderson, Robert F.; Wilson, William R.
  • International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, Vol. 51, Issue 4 https://doi.org/10.1080/09553008414552171
journal January 1987
Enhancement of chemotherapy agents journal March 1982
The clinical testing of Ro 03-8799—Pharmacokinetics, toxicology, tissue and tumor concentrations journal September 1984
A phase I study of the hypoxic cell radiosensitizer Ro-03-8799 journal September 1984
Analogues of RSU-1069: Radiosensitization and toxicity in vitro and in vivo journal July 1986
Role of Oxygen in Modifying the Radiosensitivity of E. Coli B. journal November 1956
Third International Meeting on Progress in Radio-Oncology journal January 1985
The Radiation Chemistry of Some Platinum-Containing Radiosensitizers and Related Compounds journal April 1985
NLP-1: A DNA intercalating hypoxic cell radiosensitizer and cytotoxin journal April 1989
Selective toxicity of nitracrine to hypoxic mammalian cells journal February 1984
Radiation and Platinum Drug Interaction journal January 1985
The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay journal April 1989
Radiosensitization of Mammalian Cells in Vitro by Nitroacridines journal August 1990
Radiosensitization of EMT6 cells by four platinum complexes journal May 1985